Connect with us

Health

Chronic pain with no real reason?

Published

4 minute read

Posted By: Dianne Buyks

Do you have chronic pain without a specific cause of injury? Do you have pain that has recurred several times over the course of the year, but never resolves completely? Is your pain persisting without ongoing inflammation or tissue damage? Do you have an injury that is not healing at the expected rate of recovery?

Some chronic pain conditions involving the musculoskeletal system do not seem to improve despite massage and stretching.Tight bands of muscle tissue can develop, which may create pain or cause pain by compressing a nerve that in turn causes pain. This type of dysfunction is called neuropathic pain. When the tight bands of muscle cross over a joint, additional issues can arise due to decreased space for joint movement and stiffness. This can cause issues such as bursitis, tendonitis, and arthritis. Along with muscle shortening, tissues often become supersensitive.

Gunn IMS is a total system for the diagnosis and treatment of myofascial pain syndromes (chronic pain involving the musculoskeletal system when there is no clear sign of recent injury). This approach involves assessment of the whole body to determine where pain is stemming from and what other areas need to be addressed to get long term relief.  Not all needling is Gunn IMS, although sometimes the terms can be mistakenly interchanged.

Although comparable, Gunn IMS is different from trigger point needling and acupuncture. A practitioner, knowledgeable in anatomy, completes a thorough physical examination of the whole body to find physical signs of neuropathic pain. If you show signs and symptoms indicative of neuropathic pain and there are no barriers to treatment, Gunn IMS needling can be commenced. Treatment involves a dry needling technique using acupuncture needles to loosen tight bands of muscle tissue. Needling of a normal muscle is painless; however, a shortened supersensitive muscle will grasp the needle or cause a cramping sensation. The effect of the needle causes the muscle bands to relax and lengthen, helps draw blood to the area to support healing, and stimulates the nerve to function normally again. The effects of Gunn IMS are often experienced immediately, with improvements in range of motion, muscle tension and/or pain.

If you think you can benefit from Gunn IMS, contact us and we will get you on the right path to recovery! You can find out more information about Gunn IMS and certified practitioners at www.iSTOP.org

A Little About Us:

Pursuit Physiotherapy in Red Deer, promotes balanced, healthy living through dedicated, individualized physical therapy for those in pain, unable to participate fully in their daily activities, wanting to maximize their function for work or sport, and wanting to prevent potential problems.

If it is affecting your quality of life, then we want to help you to optimize your function and minimize your pain.

We are committed to your health and want to encourage you to be too.

More from this author

Alberta

Alberta’s move to ‘activity-based funding’ will improve health care despite naysayer claims

Published on

From the Fraser Institute

By Nadeem Esmail

After the Smith government recently announced its shift to a new approach for funding hospitals, known as “activity-based funding” (ABF), defenders of the status quo in Alberta were quick to argue ABF will not improve health care in the province. Their claims are simply incorrect. In reality, based on the experiences of other better-performing universal health-care systems, ABF will help reduce wait times for Alberta patients and provide better value-for-money for taxpayers.

First, it’s important to understand Alberta is not breaking new ground with this approach. Other developed countries shifted to the ABF model starting in the early 1990s.

Indeed, after years of paying their hospitals a lump-sum annual budget for surgical care (like Alberta currently), other countries with universal health care recognized this form of payment encouraged hospitals to deliver fewer services by turning each patient into a cost to be minimized. The shift to ABF, which compensates hospitals for the actual services they provide, flips the script—hospitals in these countries now see patients as a source of revenue.

In fact, in many universal health-care countries, these reforms began so long ago that some are now on their second or even third generation of ABF, incorporating further innovations to encourage an even greater focus on quality.

For example, in Sweden in the early 1990s, counties that embraced ABF enjoyed a potential cost savings of 13 per cent over non-reforming counties that stuck with budgets. In Stockholm, one study measured an 11 per cent increase in hospital activity overall alongside a 1 per cent decrease in costs following the introduction of ABF. Moreover, according to the study, ABF did not reduce access for older patients or patients with more complex conditions. In England, the shift to ABF in the early to mid-2000s helped increase hospital activity and reduce the cost of care per patient, also without negatively affecting quality of care.

Multi-national studies on the shift to ABF have repeatedly shown increases in the volume of care provided, reduced costs per admission, and (perhaps most importantly for Albertans) shorter wait times. Studies have also shown ABF may lead to improved quality and access to advanced medical technology for patients.

Clearly, the naysayers who claim that ABF is some sort of new or untested reform, or that Albertans are heading down an unknown path with unmanageable and unexpected risks, are at the very least uninformed.

And what of those theoretical drawbacks?

Some critics claim that ABF may encourage faster discharges of patients to reduce costs. But they fail to note this theoretical drawback also exists under the current system where discharging higher-cost patients earlier can reduce the drain on hospital budgets. And crucially, other countries have implemented policies to prevent these types of theoretical drawbacks under ABF, which can inform Alberta’s approach from the start.

Critics also argue that competition between private clinics, or even between clinics and hospitals, is somehow a bad thing. But all of the developed world’s top performing universal health-care systems, with the best outcomes and shortest wait times, include a blend of both public and private care. No one has done it with the naysayers’ fixation on government provision.

And finally, some critics claim that, under ABF, private clinics will simply focus on less-complex procedures for less-complex patients to achieve greater profit, leaving public hospitals to perform more complex and thus costly surgeries. But in fact, private clinics alleviate pressure on the public system, allowing hospitals to dedicate their sophisticated resources to complex cases. To be sure, the government must ensure that complex procedures—no matter where they are performed—must always receive appropriate levels of funding and similarly that less-complex procedures are also appropriately funded. But again, the vast and lengthy experience with ABF in other universal health-care countries can help inform Alberta’s approach, which could then serve as an example for other provinces.

Alberta’s health-care system simply does not deliver for patients, with its painfully long wait times and poor access to physicians and services—despite its massive price tag. With its planned shift to activity-based funding, the province has embarked on a path to better health care, despite any false claims from the naysayers. Now it’s crucial for the Smith government to learn from the experiences of others and get this critical reform right.

Nadeem Esmail

Senior Fellow, Fraser Institute
Continue Reading

Autism

NIH, CMS partner on autism research

Published on

From The Center Square

By 

Officials at the the National Institutes of Health and the Centers for Medicare & Medicaid Services announced a partnership Wednesday to research “root causes of autism spectrum disorder.”

As part of the project, NIH will build a real-world data platform enabling advanced research across claims data, electronic medical records and consumer wearables, according to the agencies.

“We’re using this partnership to uncover the root causes of autism and other chronic diseases,” said HHS Secretary Robert F. Kennedy Jr. “We’re pulling back the curtain – with full transparency and accountability – to deliver the honest answers families have waited far too long to hear.”

CMS and NIH will start this partnership by establishing a data use agreement under CMS’ Research Data Disclosure Program focused on Medicare and Medicaid enrollees with a diagnosis of autism spectrum disorder or ASD.

“This partnership is an important step in our commitment to unlocking the power of real-world data to inform public health decisions and improve lives,” NIH Director Dr. Jay Bhattacharya said. “Linking CMS claims data with a secure real-world NIH data platform, fully compliant with privacy and security laws, will unlock landmark research into the complex factors that drive autism and chronic disease – ultimately delivering superior health outcomes to the Americans we serve.”

Researchers will focus on autism diagnosis trends over time, health outcomes from specific medical and behavioral interventions, access to care and disparities by demographics and geography and the economic burden on families and healthcare systems, according to a news release.

Continue Reading

Trending

X